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COMPARISON OF INJECTION DISCOMFORT AND ANESTHETIC DURATION OF 
PLAIN POLOCAINE VERSUS EPINEPHRINE CONTAINING ARTICAINE AND 
LIDOCAINE 
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A thesis submitted in partial fulfillment of the requirements for  
the degree Master of Science at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2013 
 
Director:  Dr. Tegwyn H. Brickhouse, DDS, PhD. 
Chair, Department of Pediatric Dentistry 
 
 
 
Purpose:  To determine possible differences in the pain level and soft tissue anesthesia 
duration of plain polocaine versus epinephrine-containing articaine and lidocaine during intraoral 
injections. 
Methods:  Forty-eight subjects received plain polocaine and one epinephrine-containing 
anesthetic.  Injections were randomized according to the first injection a)left or right buccal 
sulcus and b)epinephrine or not.  The second injections were the opposite conditions.  Subjects 
then recorded discomfort on a VAS and the time anesthesia wore off. 
Result:  The second injection’s pain rating was influenced by the first.   This carry-over 
effect makes it impossible to analyze all of the data.  An analysis of the first injection showed no 
 
 
 
significant difference between the three anesthetics.  The duration of anesthesia for epinephrine-
containing anesthetic was significantly longer than plain polocaine. 
Conclusion:  This pilot study was intended to create a sample size for a pediatric 
population.  However, due to the carry-over effect, future split-mouth studies may not be 
justified. 
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Introduction 
The advent of local anesthetic heralded a new era of patient comfort in dentistry.  
However, it is an irony that local anesthetic injection enables painless work in the oral cavity, but 
also provokes high anxiety and fear in patients.  Fear due to perceived discomfort from injections 
is considered one of the main reasons for dental anxiety.
1
  Successfully administered local 
anesthesia allows the dentist to nurture the relationship with the patient, proceed with the 
appointment, and to complete the therapeutic procedure while providing a pleasant experience. 
There are a number of factors that can influence the discomfort of a dental injection such 
as pH buffering of anesthetic solution, heating of anesthetic solution, applying pressure, 
controlling the speed of injection, use of appropriate needle gauge, use of relaxation techniques, 
use of topical anesthetic, use of aspirating syringe, and explanation of the procedure.
2
  
Parameters relating to materials, but independent of technique that might affect pain at delivery 
include the temperature and pH of the solution.  Buffering the solution with sodium bicarbonate 
can reduce the injection discomfort.
3
  However, this is not practical when prefilled dental 
cartridges are used.  Therefore, pH-dependent factors can be influenced by the choice of 
anesthetic; for example plain polocaine solutions have a pH closer to physiological pH compared 
with those that contain epinephrine.
4
  Plain local anesthetic solutions may cause less injection 
discomfort compared to epinephrine-containing local anesthetic. 
Plain polocaine has also been found to be equivalent to other epinephrine containing local 
anesthetics for achieving pulpal anesthesia.
5, 6  
 Although epinephrine in local anesthetic solutions 
are beneficial in regards to duration, this could be considered a disadvantage as well.  
 2 
 
Vasoconstriction leads to soft-tissue anesthesia that lasts several hours beyond completion of 
treatment.
7
  This can lead to attenuated capability to speak, eat, drink, or smile. Especially in 
children, accidental biting of the lips, cheeks, or tongue could cause soft-tissue damage.
7
  
Therefore decreasing the post-operative duration of soft-tissue anesthesia could decrease this 
adverse effect.  To reduce the incidence of such soft-tissue injury, some clinicians use 3% 
polocaine instead of 2% lidocaine-epinephrine.
8
  One study found a statistically significant 
difference in the duration of soft-tissue for articaine with epinephrine (140.69±49.76 minutes) as 
opposed to plain polocaine (117.52±42.99 minutes).
9
 
 
The majority of current studies on plain versus epinephrine-containing local anesthetic 
solution have been focused on its effect on cardiac patients.
10
  Meechan and Day did a study 
comparing injection discomfort levels produced by two solutions on 24 subjects (ages 20 to 24) 
in which they found plain lidocaine produces less discomfort than lidocaine with epinephrine 
when administered into the maxillary premolar buccal surface. 
4
  However, Meechan and Day 
used the traditional method of injection with short needles and aspirating syringes which did not 
control for injection speed, pressure, or penetration depth.  
An available marketed technology, The Wand (Dental Practice Systems, Herts, UK), uses 
a microprocessor and an electronically controlled motor to deliver the anesthetic solution through 
a handpiece with a needle at a constant rate and under controlled pressure.  Most current studies 
have found no difference in the pain or anxiety experienced in the conventional and Wand 
group.
11
  However, some concluded block anesthesia seems to be less painful when using the 
Wand than when using a traditional syringe.
1
  Delivery of the anesthetic solution via the Wand is 
activated with a foot pedal and the thin, light handpiece with a needle held in a pen-like grasp 
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helps to avoid variation in pressure during injection of anesthetic.
1
  The Wand will be used in 
this study to control for injection speed and pressure.  
Specific Aim 
The goal of this randomized, double-blind, split-mouth study is to determine whether 
there is a difference in the perceived pain level and soft tissue anesthesia duration of plain 
polocaine versus epinephrine-containing articaine and lidocaine during intraoral injection with 
The Wand.  
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Methods 
This study, which modeled the study done by Meechan and Day, was a pilot study carried 
out on Virginia Commonwealth subjects.  Adult human subjects are more able to give an 
accurate pain response than children
12
 and the information obtained from this pilot study will be 
used to create an appropriate sample size for the second part of this study, the pediatric 
population.  The study design was a double blind crossover study in which compared plain 
polocaine to the two most frequently used local anesthetics in pediatric dentistry, 2% lidocaine 
with 1:100,000 epinephrine and 4% articaine with 1:100,000 epinephrine.
13
  Each subject 
received plain polocaine and either epinephrine-containing lidocaine or articaine in a randomized 
order with the Wand. 
Forty-eight students (24 men, 24 women) between the ages of 22 and 32 volunteered for 
this pilot study after it was approved by the Institutional Review Board.  Subjects over 35 years 
of age, on any analgesic within the previous 72 hours, with any acute/chronic systemic 
conditions, especially neurologic conditions, pregnant, and known allergies to drugs used in this 
study were excluded.  Students were fully informed of the purpose of the study, their research 
related duties, and written consents and a health history form were completed.  A power analysis 
from the Meechan and Day study indicated that a sample size of 24 subjects provided a 90% 
chance of detecting a 10-mm difference on the visual analogue scale (VAS) at the 1% level of 
significance.  We had 48 subjects equally divided amongst the two anesthetic studies, comparing 
plain polocaine to epinephrine-containing lidocaine and plain polocaine to epinephrine-
containing articaine. 
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A pack of 3% plain polocaine, 2% lidocaine containing 1:100,000 epinephrine, and 4% 
articaine containing 1:100,000 epinephrine were obtained (Southern Anesthesia, West Columbia, 
South Carolina, USA).  To maintain double-blind conditions, research assistants who were not 
directly involved in the delivery of local anesthetic solutions removed the product identification 
label from each cartridge and replaced it with a color-coded sticker.  The stickers had the subject 
number, either “1” for 1st injection or “2” for second injection, and either “L” for left or “R” for 
right.  Therefore, the cartridges were identical except for the color-coded sticker found on each 
cartridge.  The pH of a sample of each solution from the same batch numbers was measured on 
an electronic pH meter (Mettler Toledo, Columbus, Ohio, USA) to verify the manufactuers’ 
reported pH level. 
Injections were randomized according to whether the first injection was a) on the left or 
right buccal sulcus in the maxillary first premolar region and b) epinephrine or not.  The second 
injection was the opposite site and used the other condition.  There were four double blind 
randomly assigned injection sequence groups as follows for each study: 
1) left side, no epinephrine  
2) left side, epinephrine  
3) right side, no epinephrine 
4) right side, epinephrine 
Subjects were randomized using a computer generated sequence to insure equal group sizes.   
The same operator, who was blinded to the identity of the solutions, gave all the 
injections at room temperature.  Through pre-trial measurements, the quantity of solution 
injected was 0.84 mL over 30 seconds.  For reasons of simplicity, palatal or other types of 
injections were not included.  No topical anesthetic was applied before injection because this 
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added an uncontrolled variable to the study.  Also, some studies have shown no significant 
difference between the placebo and any topical anesthetic.
14
  The Wand was used throughout and 
the 30 gauge, 1 inch needle was inserted the same depth into the injection site.  To control the 
depth of penetration into the maxillary buccal sulcus, the Wand handpiece with a half inch 
needle was inserted into the barrel of an UltraSafe aspirating syringe (Safety Syringe, Carlsbad, 
California, USA) (no longer available) which only allows the needle of the Wand to extrude the 
same length of 3mm out the tip of the syringe. 
 Immediately after each local anesthetic administration, the subjects recorded injection 
discomfort on a continuous 100-mm VAS with endpoints “no pain” and “unbearable pain.”  The 
subjects received a form with the time the anesthetic was delivered and instructed to record the 
time soft-tissue anesthesia had worn off for both sides.  Differences between solutions, left 
versus right sides, and first versus second order effects were analyzed using Student's paired t 
test modified to reflect the crossover design of the two sets of comparison groups.  Differences 
were considered significant when P<05.  Specifically, a repeated-measured mixed-model 
ANOVA was performed for each outcome (pain and time) with effects in the model to test for 
differences between the two sets of anesthesia pairs, accounting for differences also due to 
injection order and side of mouth. 
After the results from the pilot study are obtained and analyzed, a similar study will be 
carried out on a pediatric population if the results are significant and pending approval by the 
Institutional Review Boards.  Parents will provide written informed consent on behalf of their 
children and children will provide verbal assent to participate.  An appropriate sample size of 
children between the ages of 7 and 18
15
 who require restorative treatment without pulp 
 7 
 
involvement of one or more deciduous molars per sides of the maxillary arch will be 
administered anesthetic injections with identical protocols developed in this pilot study.  
Statistical Methods 
Study subjects were randomized into four sequence groups, per study.  Since this 
randomized, double-blind, split-mouth crossover study had multiple measures per subject, a 
repeated-measures mixed-model ANOVA was used to compare the VAS pain and the numbness 
duration across the study groups.  Depending upon the outcomes measured, the ANOVA may 
have included effects for Study (articaine versus polocaine, lidocaine versus polocaine), 
sequence (Artic Polo, Polo Artic, Lido Polo, Polo Lido), side (left, right), or rater (1, 2).  All 
analyses were performed using SAS software (version 9.3, SAS Institute Inc., Cary NC). 
Significance was declared at alpha=0.05.  
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Results 
The pH of the plain polocaine solution was 6.4; the epinephrine-containing lidocaine and 
articaine was 4.7 and 3.6 respectively. 
Overview 
First, the subjects included in the study groups will be described.  Followed by the 
analysis of the VAS pain scores in two parts.  The first part will show how the second injection’s 
pain rating was influenced by the first injection.   This carry-over effect in the crossover study 
makes it impossible to analyze all of the data using conventional crossover analysis.  In the 
second part, an analysis of the results from the first injection will be shown.  Lastly, the 
numbness duration will be analyzed. 
Description of subjects 
48 subjects were screened for inclusion in the study, met the inclusion criteria, and 
consented to participate in the study.  The average age of the subjects was 26 (SD = 2.35, range 
= 22 to 32) with each gender represented at 50%.  There were equal numbers of subjects 
assigned to the 2 study groups.  However, due to operator error resulting in two subjects being 
assigned to incorrect groups, 23 subjects were in the articaine versus polocaine study and 25 
were in the lidocaine versus polocaine study.  All subjects received both injected anesthetics in a 
random order and a random side.  The number of subjects in each ordering group is shown in 
Table 1.  For example, there were 7 subjects who first received an articaine injection on the left 
side, and therefore received the subsequent polocaine injection, on the right side.  As may be 
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seen, there were approximately equal numbers of injection orders in each study.  Since the study 
assignment and order were randomly assigned, there should have been no differences depending 
upon the sex or age of the subjects and the findings in this study were in agreement (P > 0.4).   
Analysis of pain VAS 
The primary outcome was the rating of pain, which was measured by two observers.  
There was never more than one unit of difference between the two observers.  The first observer 
reported slightly higher pain scores (mean difference = 0.08, SE = 0.032) but the difference was 
not significant (paired t-test P = 0.0579). 
The goal of this randomized, double-blind, split-mouth study was to determine if there 
was a difference in the perceived pain level and soft tissue anesthesia duration of plain polocaine 
versus epinephrine-containing articaine and lidocaine during intraoral injection with The Wand.  
Table 2 shows the results for each study.  In a crossover design, each subject received both 
interventions and therefore served as their own control.  Subjects are randomized to one of two 
sequences; in the articaine versus polocaine study, 12 subjects received the articaine injection 
first and then the polocaine injection (sequence = “Artic Polo”) and 11 subjects received the 
polocaine injection first and then the articaine injection (sequence = “Polo Artic”).  This design 
works as long as there is no order effects; that is, when the order of the injections does not affect 
the pain rating. As seen in Table 2, this does not seem to be the case.  When receiving articaine 
first, the difference between the articaine pain minus the polocaine pain was –1.00.  The 
difference between the articaine pain minus the polocaine pain was +3.41 when receiving 
polocaine first.  When receiving lidocaine first, the difference between the lidocaine pain minus 
the polocaine pain was –6.69.  The difference between the lidocaine pain minus the polocaine 
pain was +6.38 when receiving polocaine first.  This “carry-over effect” confounds the 
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estimation of the effect of the injection.  That is, it was impossible to use all the data to 
determine whether there was a difference in the perceived pain level of plain polocaine versus 
epinephrine-containing articaine and lidocaine.   
In the analyses that follow, we will test for a significant carry-over effect and, if it is 
present, the best that can be done is to analyze only the first injection.  The parallel coordinate 
plots of Figure 1 show one line for each subject and a red line for the average across all subjects 
in that group.  Figure 1(a) and 1(b) are those in the articaine versus polocaine study.  The plot in 
figure 1(a) shows the average trending weakly upward and the plot in figure 1(b) shows the 
average trending weakly downward.  In figure 1(c) and 1(d), the subjects in the lidocaine versus 
polocaine study are shown.  The plot in figure 1(c) shows almost all the subjects sloped upward 
and in the figure 1(d) plot almost all the subjects sloped downward.  If there had been no carry-
over effect, the lines should have trended in the same direction.  That is, if order did not matter, 
the slope of the lines representing the effect of epinephrine versus no epinephrine would have 
been similar.  They were not. 
The VAS pain levels were analyzed using a repeated-measures mixed-model ANOVA 
with the following factors: study (articaine versus polocaine, lidocaine versus polocaine), 
sequence (Artic Polo, Polo Artic, Lido Polo, Polo Lido), side (left, right), and rater (1, 2).  The 
results shown in Table 3 showed there was a significant carry-over effect (P < .0001).  This is 
seen in the interaction test, “Inject*Sequence(Study)”; this test asked if the effect of the two 
injections were the same across the two sequences used within each study.  Also evident if the 
data in Table 2, the difference between the injection containing epinephrine and that without 
epinephrine was different depending upon which injection came first. 
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The averages for each group’s VAS pain score are given in Table 4 and include 95% 
confidence intervals and P-values comparing the two injections within each sequence.  For the 
articaine versus polocaine subjects there was no difference between the two injection order 
groups, “Artic Polo” sequence (P = 0.554) and “Polo Artic” sequence (P = 0.099).  However, the 
signs for the differences were reversed in the two sequences, an indication of a carry-over effect.  
See Figure 2 for an illustration of this reversal.  For the lidocaine versus polocaine subjects, there 
were similar results as in the articaine versus polocaine subjects with respect to the signs 
indicating a carry-over effect.  Again, the signs for the differences in the two sequences were 
opposite, which indicates a carry-over effect.  With clear indication that the second pain rating is 
influenced by the first, the second injection data cannot be used to answer the aim of the study.  
The best that can be done is to analyze only the first injection’s data. 
A repeated-measures mixed-model ANOVA was run with the following factors 
considered: Injection (articaine, lidocaine, polocaine), rater (1,2), and side (L, R).  Table 5 shows 
the results, and there was no significant difference between the three injections (P = 0.658). 
The average VAS pain values for each of the groupings are shown in Table 6.  The pain 
levels are comparable and in the range from 12 to 17mm. 
A repeated-measures mixed-model ANOVA was run with the following factors 
considered: Study (articaine versus polocaine, lidocaine versus polocaine), injection (articaine, 
lidocaine, polocaine), rater (1,2), side (L, R), sex (male, female), age (years).  Table 7 shows the 
results, and there was no significant difference between the three injections (P > 0.9).  There was 
also no left versus right side difference, no significant difference between the raters, no 
relationship with age, no male versus female difference, and no difference between the subjects 
in the two studies. 
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Analysis of Numbness Duration 
As a secondary aim, the study sought to compare the duration of numbness in the groups.  
The minutes were analyzed using a repeated-measures mixed-model ANOVA with the following 
factors: study (articaine versus polocaine, lidocaine versus polocaine), sequence (Artic Polo, 
Polo Artic, Lido Polo, Polo Lido), and side (left, right).  The results are shown in 8.  In this case, 
the results are clear.  The differences between the epinephrine injection and the non-epinephrine 
injection are similar across the two sequences (P = 0.427).  The primary finding was a significant 
difference between the numbness duration of the epinephrine injections and the non-epinephrine 
injections (P < .0001). 
The average duration of numbness in all the study groups is shown in Table 8.  As may 
be seen from the table, in all cases the articaine or lidocaine injections had longer duration than 
did the polocaine injections. 
Since the sequence/order of injections had no effect on numbness, the results may be 
collapsed across these groups.  These averages are shown in Table 9.  The effects of polocaine 
dissipated approximately wore off approximately an hour earlier. 
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Discussion 
A number of factors can be used to reduce the discomfort of a local anesthetic injection 
such as pH buffering of an anesthetic solution, heating of an anesthetic solution, applying 
pressure, controlling the speed of injection, use of appropriate needle gauge, relaxation 
techniques, topical anesthetic, aspirating syringe, and an explanation of the procedure.
2
  
However, there is little evidence in the literature that the various methods proposed are 
dependable. 
In addition to the techniques listed above, pH of the solution which is influenced by the 
choice of anesthetic has been proposed as being significant in relation to injection pain.  There is 
evidence in the medical literature that pH influences injection discomfort.
16
  However, there is 
little evidence in the dental literature that this occurs with intraoral anesthesia.  Meechan noted 
that the injection into the maxillary premolar buccal sulcus of lidocaine with epinephrine (lower 
pH) produced more discomfort than plain lidocaine
4
.  On the other hand, Wahl
17
 reported no 
difference in injection discomfort during maxillary buccal infiltrations and inferior alveolar 
nerve blocks with prilocaine plain versus lidocaine with 1:100,000 epinephrine. 
This study was designed to determine the influence of different commercially available 
local anesthetic solutions on injection discomfort in the mouth.  All other parameters were 
standardized.  The plain solution had a pH closer to physiological than the epinephrine-
containing anesthetics.  The results of this investigation differ with those of Meechan
4
.  This may 
be due to the different rate of injections.  Meechan delivered 1.0 mL over 30 seconds whereas 
 14 
 
0.84 mL was delivered over the same period in this study.  These findings are in agreement with 
those of Wahl’s study17, which analyzed 334 injections in 310 patients using topical anesthetic 
prior to administration of anesthetics.  In this split-mouth pilot study, it was elected not to use 
topical anesthetic to eliminate variations in the amount used and possible attenuation of pain. 
The power analysis in Meechan’s study dictated that a sample size of 24 subjects 
provided a 90% chance of detecting a 10-mm difference in the VAS at the 1% level
4
.  However, 
the carry-over effect eliminated the subjects being their own control for this split-mouth study.  
Therefore, the number of subjects in this study (24 per study) may be too small to allow for 
definitive conclusions.   
In addition, it is apparent that injection discomfort varies in different areas of the mouth.  
The maxillary buccal sulcus in the premolar area is usually considered a relatively comfortable 
region for local anesthetic administration.  Data was entered into the Meechan
4
 study only if one 
or both scores on the pair were at least 30mm on the VAS because the sensitivity of the acute 
pain trials is dependent on the production of moderate paint.  This resulted in 50% of the 
volunteers who did not achieve an injection discomfort score that merited inclusion in the study.  
If the same VAS criteria were used, 83% of subjects would have been excluded.  Low VAS 
scores in this study, relative to Meechan’s study, may be due to the Wand delivering a more 
comfortable injection method.  Since we did not include palatal injections in our study, there 
may be a difference in the pain response between anesthetics for this injection site. 
Although the results of this investigation suggest no decrease in discomfort for the use of 
plain polocaine solutions, this local anesthetic may be preferred for restoratives on the pediatric 
patients.  Epinephrine causes soft-tissue anesthesia that may last hours beyond completion of 
 15 
 
treatment.
7
  In this study, we found a statistically significant difference between duration of soft 
tissue numbness of plain anesthetic versus epinephrine-containing anesthetic.  Polocaine 
averaged 87 minutes, articaine with epinephrine averaged 150 minutes, and lidocaine with 
epinephrine averaged 152 minutes.  This prolonged numbness can lead to accidental lip, cheek, 
or tongue biting in children.
7
  To reduce the incidence of such soft-tissue injury, some clinicians 
use 3% polocaine instead of 2% lidocaine-epinephrine.
8
  Although this study does not investigate 
pulpal anesthesia, 3% polocaine has been found to be equivalent to other anesthetic solutions for 
achieving pulpal anesthesia and inferior alveolar nerve blocks.
6
 
This present study also showed a statistically significant order effect in relation to the 
maxillary infiltration injections.  The fact that the order of injection affects the injection pain 
confirms results of other investigations on intraoral injection discomfort.  For example, Martin
18
 
found that patients who received bilateral buccal injections in the maxillary premolar region 
reported the second injection to be significantly more uncomfortable than the first 
administration.  This implies the best chance of providing comfortable anesthetic delivery is at 
the first injection. Thus, choosing an intraoral area where such possibility exists as the first site 
of injection is supported.  If additional administrations can be delivered into areas where the 
initial anesthetic has spread, the overall pain experience for the patient might be reduced. 
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Conclusion 
 There was no significant difference in the perceived pain on injection with plain polocaine 
versus epinephrine containing anesthetics. 
 Under the methods of this study, regardless of which anesthetic administered, subjects 
usually experienced only mild pain on injection. 
 Duration of soft tissue anesthesia for epinephrine-containing anesthetic was significantly 
longer than plain polocaine which may increase the chances for soft tissue trauma. 
 Second injection was significantly more painful than the first injection. 
 Due to the carry-over effect, future split-mouth studies may not be justified. 
 Further study of the role of pH and injection pain is warranted. 
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Table 1: Random Order of First Injection 
  
First injection 
 
Second injection 
Study N Side Product   Side Product 
Articaine vs Polocaine 
   
 
7 L Articaine 
 
R Polocaine 
 
6 L Polocaine 
 
R Articaine 
 
5 R Articaine 
 
L Polocaine 
  5 R Polocaine   L Articaine 
 
Lidocaine vs Polocaine 
   
 
7 L Lido 
 
R Polocaine 
 
6 L Polocaine 
 
R Lido 
 
6 R Lido 
 
L Polocaine 
  6 R Polocaine   L Lido 
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Table 2: Summary 
 
Abbreviations: SD=standard deviation, Artic=articaine, Polo=polocaine, Lido=lidocaine 
 
 
 
 
 
 
 
 
 
 
 
 
   
Pain VAS 
Sequence Injection Order n Mean SD 
articaine vs polocaine subjects 
Artic Polo Artic 1st 12 16.54 8.12 
 
Polo 2nd 12 17.54 9.96 
 
Artic-Polo 
 
–1.00 
 Polo Artic Artic 2nd 11 20.27 16.25 
 
Polo 1st 11 16.86 14.88 
 
Artic-Polo 
 
+3.41 
 lidocaine vs polocaine subjects 
Lido Polo Lido 1st 13 12.69 8.82 
 
Polo 2nd 13 19.38 9.88 
 
Lido-Polo 
 
–6.69 
 Polo Lido Lido 2nd 12 18.50 16.37 
 
Polo 1st 12 12.13 7.66 
  Lido-Polo   +6.38   
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Table 3: ANOVA results 
Effect Num DF Den DF F P 
Study 1 44 0.50 0.4822 
Sequence 2 44 0.08 0.9259 
Injection(Study) 2 138 0.32 0.7251 
Rater 1 138 0.01 0.9346 
Side 1 138 1.49 0.2243 
Inject*Sequence(Study) 2 138 12.22 <.0001 
Abbreviations: Num DF=numerator degrees of freedom, Den DF=denominator degrees of 
freedom, F=F test, P=P-value 
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Table 4: Average VAS Pain in Each Study Group 
   
Pain VAS 
 Sequence Injection Order n Estimate SE 95% CI P 
articaine vs polocaine subjects 
Artic Polo Artic 1st 12 16.44 3.17 10.09 22.79 
 
 
Polo 2nd 
 
17.65 3.17 11.30 23.99 
 
 
Artic-Polo 
 
–1.21 2.04 -5.23 2.82 0.5540 
Polo Artic Artic 2nd 11 20.33 3.31 13.70 26.96 
 
 
Polo 1st 
 
16.81 3.31 10.18 23.44 
 
 
Artic-Polo 
 
+3.52 2.12 -0.67 7.71 0.0989 
lidocaine vs polocaine subjects 
Lido Polo Lido 1st 13 12.64 3.04 6.55 18.74 
 
 
Polo 2nd 
 
19.43 3.04 13.33 25.53 
 
 
Lido-Polo 
 
–6.79 1.95 -10.64 -2.93 0.0007 
Polo Lido Lido 2nd 12 18.50 3.17 12.15 24.85 
 
 
Polo 1st 
 
12.13 3.17 5.78 18.47 
   Lido-Polo   +6.38 2.03 2.37 10.38 0.0020 
Abbreviations: Artic=articaine, Polo=polocaine, Lido=lidocaine, SE=standard error, 
CI=confidence interval, P=P-value 
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Table 5: ANOVA Results of the First Injection 
Effect Num DF Den DF F P-value 
Injection 2 44 0.42 0.6578 
Rater 1 47 3.78 0.0579 
Side 1 44 0.01 0.9162 
Abbreviations: Num DF=numerator degrees of freedom, Den DF=denominator degrees of 
freedom, F=F test, P=P-value 
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Table 6: Average VAS pain of the First Injection, by Group 
 
 
 
 
 
 
 
  
Abbreviations: Artic=articaine, Polo=polocaine, Lido=lidocaine, SE=standard error, 
CI=confidence interval 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VAS Pain 
Group Average SE 95% CI 
Injection 
Artic 16.57 3.04 10.44 22.70 
Lido 12.70 2.92 6.83 18.58 
Polo 14.40 2.19 9.98 18.82 
Rater 
1 14.61 1.59 11.41 17.81 
2 14.51 1.59 11.31 17.70 
Side 
L 14.40 2.10 10.17 18.62 
R 14.72 2.30 10.09 19.35 
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Table 7: alternate ANOVA Results of the First Injection 
Source 
Num 
DF 
Den 
DF F 
P-
value 
Side 1 41 0.12 0.7258 
Rater 1 47 3.78 0.0579 
Age 1 41 3.19 0.0814 
Sex 1 41 1.62 0.2104 
Study 1 41 1.96 0.1691 
Injection[Study] 2 41 0.05 0.9516 
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Table 8: ANOVA results of Numbness 
Effect Num DF Den DF F P 
Study 1 44 0.02 0.8883 
Sequence(Study) 2 44 0.73 0.4862 
Injection(Study) 2 43 19.49 <.0001 
Side 1 43 0.36 0.5529 
Inject*Sequence(Study) 2 43 0.87 0.4274 
Abbreviations: Num DF=numerator degrees of freedom, Den DF=denominator degrees of 
freedom, F=F test, P=P-value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
 
 
 
 
Table 9: Average Duration for all Study Groups 
   
Duration (minutes) 
 Sequence Injection Order n Estimate SE 95% CI P 
articaine vs polocaine subjects 
Artic Polo Artic 1st 12 162.43 15.32 131.98 192.87 
 
 
Polo 2nd 
 
87.91 15.32 57.46 118.35 
 
 
Artic-Polo 
 
74.52 20.48 33.22 115.82 0.0007 
Polo Artic Artic 2nd 11 137.45 15.98 105.68 169.21 
 
 
Polo 1st 
 
86.19 15.98 54.42 117.95 
 
 
Artic-Polo 
 
51.26 21.34 8.23 94.29 0.0207 
lidocaine vs polocaine subjects 
Lido Polo Lido 1st 13 137.85 14.70 108.63 167.07 
 
 
Polo 2nd 
 
88.15 14.70 58.93 117.37 
 
 
Lido-Polo 
 
49.70 19.62 10.13 89.28 0.0150 
Polo Lido Lido 2nd 12 167.00 15.29 136.60 197.40 
 
 
Polo 1st 
 
87.42 15.29 57.02 117.82 
   Lido-Polo   79.58 20.41 38.43 120.74 0.0003 
Abbreviations: Artic=articaine, Polo=polocaine, Lido=lidocaine, SE=standard error, 
CI=confidence interval, P=P-value 
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Table 10: Average Duration for the Injection Groups 
 
Duration (minutes) 
Injection Estimate SE 95% CI P 
 
articaine vs polocaine subjects 
Artic 149.94 11.06 127.96 171.92 
 Polo 87.05 11.06 65.06 109.03 
   62.89 14.76 33.12 92.66 0.0001 
 
lidocaine vs polocaine subjects 
Lido 152.43 10.61 131.34 173.51 
 Polo 87.78 10.61 66.70 108.86 
   64.64 14.16 36.09 93.19 <.0001 
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Figure 1: Individual VAS Pain Ratings in the Two Groups of Subjects 
Articaine Study Subjects 
a)                                                                      b) 
                           
Lidocaine Study Subjects 
c)                                                                      d)                                          
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Figure 2: Average VAS Pain in Each Study Group 
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Comparison of Intraoral Injection Pain from Plain Polocaine versus Epinephrine-Containing 
Articaine Local Anesthetic Solutions 
 
 
Health History Form 
 
Name:_________________    Contact number:______________    Date of Birth:____________ 
 
Are you presently in good general health? □ yes  □ no 
 If no, please explain:_______________________________________________________ 
Are you under the care of a physician? □ yes  □ no 
 If no, please explain:_______________________________________________________ 
Have you been admitted to the hospital? □ yes  □ no 
 If yes, please explain:______________________________________________________ 
Have you had any surgeries?  □ yes  □ no 
 If yes, please explain:______________________________________________________ 
 
Do you have any heart problems? □ yes  □ no 
 If yes, please explain:______________________________________________________ 
Do you have any breathing problems? □ yes  □ no 
 If yes, please explain:______________________________________________________ 
Do you have any blood related problems?  □ yes  □ no 
 If yes, please explain:______________________________________________________ 
Do you have any head, ear, eye, nose, or throat problems?  □ yes  □ no 
 If yes, please explain:______________________________________________________ 
Do you have any digestive problems? □ yes  □ no 
 If yes, please explain:______________________________________________________ 
Do you have any endocrine problems (such diabetes, thyroid, etc)? □ yes  □ no 
 If yes, please explain:______________________________________________________ 
Do you have any nervous system problems (stroke, epilepsy, etc)?  □ yes  □ no 
 If yes, please explain:______________________________________________________ 
Do you have any psychiatric problems? □ yes  □ no 
 34 
 
 If yes, please explain:______________________________________________________ 
Do you have any other health concerns? □ yes  □ no 
 If yes, please explain:______________________________________________________ 
 
For women only – are you currently nursing/pregnant? □ yes  □ no 
 
 
Family History – cancer, arthritis, neurologic, heart disease, hypertension, anesthesia 
complications? 
 ________________________________________________________________________  
 ________________________________________________________________________  
 
Social History – smoking/tobacco use, alcoholic beverages, and/or recreational drugs? 
 ________________________________________________________________________  
 ________________________________________________________________________  
 
Allergies – Food or drug? 
 ________________________________________________________________________  
 ________________________________________________________________________  
 
 
Medications? 
 ________________________________________________________________________  
 ________________________________________________________________________  
 
Have you taken any analgesics within the past 72 hours? 
 ________________________________________________________________________  
 ________________________________________________________________________  
 
Have you ever had complications from local anesthetics (numbing medication) in the past? 
 ________________________________________________________________________  
 ________________________________________________________________________  
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Comparison of Injection Discomfort and Anesthetic Duration of Plain Polocaine versus 
Epinephrine containing Articaine and Lidocaine 
 
Dental Resident (Dana Doan, DDS) Script for Study Participation: 
 
You are being asked to participate in a study for my research project. 
 
The purpose of this study is to determine if there is a difference in the discomfort and anesthetic 
duration commonly experienced by patients following the injection of plain polocaine versus 
epinephrine containing articaine or lidocaine.   
Immediately after the two local anesthetic administration, you will be asked to record injection 
discomfort on a continuous 100-mm visual analogue scale (VAS) with endpoints "no pain" and 
"unbearable pain.  You will also be asked to record the times at which soft tissue anesthesia 
wears off for both sides. 
Personal information will be collected concerning your health history and the information will be 
kept anonymous and secure. 
Your participation is voluntary - meaning you may stop or withdraw from the study at any point.  
Volunteering for this study will not affect or change your grade for the pediatric dentistry 
rotation. 
Your participation will potentially help pediatric dentists reduce patient’s discomfort associated 
with injections. 
 
You will be compensated $20 for your participation after both injections are completed, you have 
provided the requested feedback on your pain level, and the requested feedback on durations at 
which the soft tissue anesthesia wears off. 
 
If you choose to participate, read over the Consent Form and sign it after all of your questions 
have been answered.  Also, fill out the Health History Form. 
 
Thank you for your time and participation with this study. 
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Comparison of Injection Discomfort and Anesthetic Duration of Plain Polocaine 
versus Epinephrine containing Articaine and Lidocaine 
 
Anesthetic Duration Sheet 
 
 
 
Subject # _______ 
 
 
Time of 1
st
 injection: ______________  Left/Right 
 Time soft tissue anesthesia for Left/Right side wears off: ______________  
 
 
Time of 2
nd
 injection: ______________  Left/Right 
 Time soft tissue anesthesia for Left/Right side wears off: ______________  
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